Substrate
science

Webinar to Examine Vaccine Design and Immune Response Analysis

A webinar scheduled for 20 May will discuss how activating the innate immune system and adaptive memory contribute to vaccine performance. The session is sponsored by Westlake.

SC
1 source·May 18, 4:32 PM(11 days ago)·1m read
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

A webinar on vaccine design and immune response analysis is scheduled for 20 May at 8 a.m. ET. The program will cover the role of innate immune system activation and adaptive memory in improving vaccine immunogenicity and efficacy.

The session is presented as part of a series focused on global health security topics. Registration information and additional details are available through the hosting platform.

Key Facts

Webinar date
20 May at 8 a.m. ET
Focus areas
Innate immune activation and adaptive memory
Sponsor
Westlake

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count67 words
PublishedMay 18, 2026, 4:32 PM

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science4 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 hrs agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science6 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source